Literature DB >> 2112050

Nomenclature for synthetic peptides representative of immunoglobulin chain sequences. WHO-IUIS Nomenclature Sub-Committee.

.   

Abstract

The source (species of origin), type, and subgroup (where applicable) of the immunoglobulin chain are indicated prior to the numbers of the first and last amino acid residues comprising the synthesized sequence (stated in parentheses), e.g., human gamma 1 (289-298) or rat epsilon (143-147). Square brackets indicate that the peptide is an analogue; substituted amino acids are identified by the three-letter code; superscripted numbers indicating the residue at which the substitution, removal or addition occurs. Further substitutions are specified within round brackets. For example, human gamma 1 (289-298) [D-Thr298] and human gamma 1 (289-298) [Asn (CHO)297].

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112050      PMCID: PMC2393011     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  14 in total

1.  An IgG primary sequence exposure theory for complement activation using synthetic peptides.

Authors:  R J Boackle; B J Johnson; G B Caughman
Journal:  Nature       Date:  1979-12-13       Impact factor: 49.962

2.  Peptide inhibition of the Prausnitz-Küstner reaction.

Authors:  R N Hamburger
Journal:  Science       Date:  1975-08-01       Impact factor: 47.728

3.  The binding site for C1q on IgG.

Authors:  A R Duncan; G Winter
Journal:  Nature       Date:  1988-04-21       Impact factor: 49.962

4.  The effect of synthetic peptides corresponding to Fc sequences in human IgG1 on various steps in the B cell activation pathway.

Authors:  G Sármay; D R Stanworth; R Szigeti; E Klein; K Reguly; R Pálvölgyi; J Gergely
Journal:  Eur J Immunol       Date:  1988-02       Impact factor: 5.532

5.  The mast cell binding site on human immunoglobulin E.

Authors:  B Helm; P Marsh; D Vercelli; E Padlan; H Gould; R Geha
Journal:  Nature       Date:  1988-01-14       Impact factor: 49.962

Review 6.  Application of synthetic peptides representative of immunoglobulin sequences to the delineation of receptor binding and signalling processes.

Authors:  D R Stanworth
Journal:  Mol Immunol       Date:  1982-10       Impact factor: 4.407

7.  Isolation and identification of a biologically active peptide derived from the CH3 domain of human IgG1.

Authors:  E L Morgan; T E Hugli; W O Weigle
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

8.  "Tuftsin": a natural phagocytosis stimulating peptide.

Authors:  V A Najjar; K Nishioka
Journal:  Nature       Date:  1970-11-14       Impact factor: 49.962

9.  Inhibition of C1-mediated immune hemolysis by monomeric and dimeric peptides from the second constant domain of human immunoglobulin G.

Authors:  T J Lukas; H Muñoz; B W Erickson
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

10.  The use of synthetic gamma-chain peptides in the localization of the binding site(s) on human IgG1 for the Fc receptors of homologous monocytes and heterologous mouse macrophages.

Authors:  A Ratcliffe; D R Stanworth
Journal:  Immunol Lett       Date:  1982-04       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.